Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocugen (OCGN) EBITDA: 2014-2024

Historic EBITDA for Ocugen (OCGN) over the last 11 years, with Dec 2024 value amounting to -$54.0 million.

  • Ocugen's EBITDA fell 54.18% to -$20.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$64.0 million, marking a year-over-year decrease of 25.10%. This contributed to the annual value of -$54.0 million for FY2024, which is 14.36% up from last year.
  • Ocugen's EBITDA amounted to -$54.0 million in FY2024, which was up 14.36% from -$63.1 million recorded in FY2023.
  • Ocugen's 5-year EBITDA high stood at -$21.8 million for FY2020, and its period low was -$86.8 million during FY2022.
  • Over the past 3 years, Ocugen's median EBITDA value was -$63.1 million (recorded in 2023), while the average stood at -$68.0 million.
  • In the last 5 years, Ocugen's EBITDA tumbled by 167.46% in 2021 and then climbed by 27.30% in 2023.
  • Ocugen's EBITDA (Yearly) stood at -$21.8 million in 2020, then slumped by 167.46% to -$58.4 million in 2021, then crashed by 48.68% to -$86.8 million in 2022, then rose by 27.30% to -$63.1 million in 2023, then grew by 14.36% to -$54.0 million in 2024.